Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 1, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, January 31, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Steven Seedhouse Upgraded (ARCT) to Hold on, Jan 31st, 2022
Steven Seedhouse of Raymond James, Upgraded "Arcturus Therapeutics Holdings Inc." (ARCT) to Hold on, Jan 31st, 2022.
Steven has made no other calls on ARCT in the last 4 months.
There is 1 other peer that has a rating on ARCT. Out of the 1 peers that are also analyzing ARCT, 0 agree with Steven's Rating of Hold.
This is the rating of the analyst that currently disagrees with Steven
- Gena Wang of "Barclays" Maintained at Sell with Decreased Target to $31 on, Tuesday, November 9th, 2021
